All changes for the tissue cardiovascular system (62)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1292
NYN domain and retroviral integrase containing
Molecular
heart
Mouse
Nynrin
8.0% Increase Gene Expression Level
DAA1298
opsin 1 (cone pigments), long-wave-sensitive
Molecular
heart
Mouse
Opn1lw
19.0% Increase Gene Expression Level
DAA622
Acute myocardial infarction
Pathological
heart
Human
—
SeriesMorbidity
DAA709
Coronary artery disease incidence increases
Pathological
heart, artery
Human
—
—
DAA1023
Coronary heart disease (Female)
Pathological
heart
Human
—
SeriesIncidence
DAA1022
Coronary heart disease (Male)
Pathological
heart
Human
—
SeriesIncidence
DAA2021
Diminution in the resting cardiac output
Physiological
heart
Human
—
—
DAA617
Diseases of heart
Pathological
heart
Human
—
SeriesMorbidity
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA710
Facets of heart physiology altered during exercise
Physiological
heart
Human
—
—
DAA711
Heart physiology measurements unchanged
Physiological
heart
Human
—
—
DAA712
Heart physiology parameters altered
Physiological
heart
Human
—
—
DAA1025
Heart attack (Female)
Pathological
heart
Human
—
SeriesIncidence
DAA1024
Heart attack (Male)
Pathological
heart
Human
—
SeriesIncidence
DAA1021
Heart disease (Female)
Pathological
heart
Human
—
SeriesIncidence
DAA1020
Heart disease (Male)
Pathological
heart
Human
—
SeriesIncidence
DAA625
Heart failure
Pathological
heart
Human
—
SeriesMorbidity
DAA620
Hypertensive heart and renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA619
Hypertensive heart disease
Pathological
heart
Human
—
SeriesMorbidity
DAA703
Wall increases in thickness
Physiological
left ventricle
Human
—
—
DAA704
Cellular hypertrophy in left ventricular wall
Physiological
left ventricle
Human
—
—
DAA709
Coronary artery disease incidence increases
Pathological
heart, artery
Human
—
—
DAA681
Metabolic syndrome components associated with measures of arterial stiffness
Physiological
artery
Human
—
—
DAA1046
Hypertension (high BP or taking meds) (Male)
Pathological
artery
Human
—
SeriesIncidence
DAA628
Atherosclerosis
Pathological
artery
Human
—
SeriesMorbidity
| Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
|---|---|---|---|---|---|---|---|
| DAA1292 | NYN domain and retroviral integrase containing | Molecular | heart | Mouse | Nynrin | 8.0% Increase Gene Expression Level | |
| DAA1298 | opsin 1 (cone pigments), long-wave-sensitive | Molecular | heart | Mouse | Opn1lw | 19.0% Increase Gene Expression Level | |
| DAA622 | Acute myocardial infarction | Pathological | heart | Human | — | SeriesMorbidity | |
| DAA709 | Coronary artery disease incidence increases | Pathological | heart, artery | Human | — | — | |
| DAA1023 | Coronary heart disease (Female) | Pathological | heart | Human | — | SeriesIncidence | |
| DAA1022 | Coronary heart disease (Male) | Pathological | heart | Human | — | SeriesIncidence | |
| DAA2021 | Diminution in the resting cardiac output | Physiological | heart | Human | — | — | |
| DAA617 | Diseases of heart | Pathological | heart | Human | — | SeriesMorbidity | |
| DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
| DAA710 | Facets of heart physiology altered during exercise | Physiological | heart | Human | — | — | |
| DAA711 | Heart physiology measurements unchanged | Physiological | heart | Human | — | — | |
| DAA712 | Heart physiology parameters altered | Physiological | heart | Human | — | — | |
| DAA1025 | Heart attack (Female) | Pathological | heart | Human | — | SeriesIncidence | |
| DAA1024 | Heart attack (Male) | Pathological | heart | Human | — | SeriesIncidence | |
| DAA1021 | Heart disease (Female) | Pathological | heart | Human | — | SeriesIncidence | |
| DAA1020 | Heart disease (Male) | Pathological | heart | Human | — | SeriesIncidence | |
| DAA625 | Heart failure | Pathological | heart | Human | — | SeriesMorbidity | |
| DAA620 | Hypertensive heart and renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
| DAA619 | Hypertensive heart disease | Pathological | heart | Human | — | SeriesMorbidity | |
| DAA703 | Wall increases in thickness | Physiological | left ventricle | Human | — | — | |
| DAA704 | Cellular hypertrophy in left ventricular wall | Physiological | left ventricle | Human | — | — | |
| DAA709 | Coronary artery disease incidence increases | Pathological | heart, artery | Human | — | — | |
| DAA681 | Metabolic syndrome components associated with measures of arterial stiffness | Physiological | artery | Human | — | — | |
| DAA1046 | Hypertension (high BP or taking meds) (Male) | Pathological | artery | Human | — | SeriesIncidence | |
| DAA628 | Atherosclerosis | Pathological | artery | Human | — | SeriesMorbidity |